Immune checkpoint inhibitor-associated colitis: from mechanism to management

L Tang, J Wang, N Lin, Y Zhou, W He, J Liu… - Frontiers in …, 2021 - frontiersin.org
Immune checkpoint inhibitors (ICIs), as one of the innovative types of immunotherapies,
including programmed cell death-1 (PD-1), programmed cell death-ligand 1 (PD-L1), and …

Progress on the study of the anticancer effects of artesunate

X Yang, Y Zheng, L Liu, J Huang… - Oncology …, 2021 - spandidos-publications.com
Artesunate (ART) is a derivative of artemisinin that is extracted from the wormwood plant
Artemisia annua. ART is an antimalarial drug that has been shown to be safe and effective …

The effect of age on the opportunity to receive cancer treatment

S Habbous, SMH Alibhai, IB Menjak, K Forster… - Cancer …, 2022 - Elsevier
Introduction Older adults with cancer may not receive the same opportunities for treatment
as younger patients. In this retrospective population-based cohort study, we explored …

Surgery versus radiotherapy in octogenarians with stage Ia non‑small cell lung cancer: propensity score matching analysis of the SEER database

L Ni, G Lin, Z Zhang, D Sun, Z Liu, X Liu - BMC Pulmonary Medicine, 2022 - Springer
Objectives To compare overall survival (OS) and cancer-specific survival (CSS) outcomes of
surgery with radiotherapy in octogenarians with stage Ia non-small cell lung cancer …

Barriers to Access: Global Variability in Implementing Treatment Advances in Lung Cancer.

M Febbraro, A Gheware, T Kennedy, D Jain… - American Society of …, 2022 - europepmc.org
Globally, lung cancer is the second most-diagnosed cancer and is the leading cause of
cancer death. Advances in science and technology have contributed to improvements in …

Disparity in Treatment Receipt by Race and Treatment Guideline Revision Years for Stage 1A Non-Small Cell Lung Cancer Patients in the US

N Patel, S Karimi, ME Egger, B Little… - Journal of Racial and …, 2024 - Springer
Introduction Treatment guideline revision introduced by the National Comprehensive
Cancer Network (NCCN) is referred to by about 95% of the United States (US) oncologists in …

[HTML][HTML] Octogenarians may benefit from stage-specific small cell lung cancer treatment

B Zhou, Q Li, L Qin, Z Li, K Jin, J Dai, Y Zhu… - Translational Lung …, 2021 - ncbi.nlm.nih.gov
Background Our study investigates treatment profiles in octogenarian patients with small cell
lung cancer (SCLC) and assesses each treatment's role in a stage-specific manner …

[PDF][PDF] Prognostic factors of operated stage I non-small cell lung cancers: A tertiary center long-term outcomes

MV Dogru, CB Sezen, V Erdogu, C Aker, A Alp… - Med Bull …, 2021 - academia.edu
Aim: This study aimed to evaluate prognostic factors influencing survival in patients who
underwent surgical resection of Stage I nonsmall cell lung cancer (NSCLC) in our center …

The effect of lymph node ratio on survival in non-small-cell lung cancer

CB Sezen, CE Kalafat, MV Doğru, C Aker… - Acta Chirurgica …, 2023 - Taylor & Francis
Background The aim of this study was to evaluate the effect of prognostic factors and lymph
node ratio (LNR) on survival in patients with resected non-small-cell lung cancer (NSCLC) …

Clinical and environmental factors affecting the survival outcomes among stage 1A TN0M0 first primary non-small cell lung carcinoma patients in the United States.

N Patel - 2023 - ir.library.louisville.edu
Background: Lung cancer is the second leading cause of death in the United States (US).
The most prevalent histological type of lung cancer is Non-Small Cell Lung Cancer …